Earnings Call · Q4 FY2023·2024-02-28

Q4 23EPS -100.00%*·Rev n/aQ3 23EPS +29.63%·Rev n/aQ2 23EPS +17.72%·Rev n/aQ1 23EPS +17.53%·Rev n/a⚠ consensus missing

Mirum Pharmaceuticals, Inc. MIRM

Andrew McKibben — Investor Relations or Corporate Communications (inferred from hosting the call)

Chris Peetz — Chief Executive Officer

Peter Radovich — President and Chief Operating Officer

Joanne Quan — Chief Medical Officer

Eric Bjerkholt — Chief Financial Officer

−0.6%1d on move date−1.0% vs SPY3d−0.7%5d−1.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MIRM calls or request research access.

More MIRM calls Browse calls Request research access